Regulation of ANG II receptor in hypertension: Role of ANG II

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 1 40-1, 1996, Pages

  Wang, Donna H ^a   Yao, Aqing ^a   Zhao, Huawei ^a   Dipette, Donald J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

angiotensin II type 1 receptor; gene expression; losartan; ramipril; transforming growth factor 1

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HYPERTENSION; KIDNEY PARENCHYMA; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; RNA ANALYSIS;

EID: 33750796465     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.1.h120     Document Type: Article

References (35)

1. Amann, K., T. Irzyniec, G. Mall, and E. Ritz. The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rats: a stereological analysis. J. Hypertens. 11: 969-975, 1993.
2. Anderson, S., and B. M. Brenner. Therapeutic benefit of converting-enzyme inhibition in progressive renal disease. Am. J. Hypertens. 1: 380S-383S, 1988.
3. Baboolal, K., and T. W. Meyer. The effect of acute angiotensin II blockade on renal function in rats with reduced renal mass. Kidney Int. 46: 980-985, 1994.
4. Barnard, J. A., R. M. Lyons, and H. L. Moses. The cell biology of transforming growth factor-β. Biochim. Biophys, Acta 1032: 79-87, 1990.
5. Border, W. A., and N. A. Noble. Cytokines in kidney disease: the role of transforming growth factor. Am. J. Kidney Dis. 22: 105-113, 1993.
6. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
7. Brooks, D. P., L. C. Contino, W. Trizna, R. M. Edwards, E. H. Ohlstein, and H. A. Solleveld. Effect of enalapril or the thromboxane receptor antagonist, Daltroban, in rats with subtotal renal ablation. J. Pharmacol. Exp. Ther. 253: 119-123, 1990.
8. Brown, L., and C. Sernia. Angiotensin receptors in cardiovascular diseases. Clin. Exp. Pharmacol. Physiol 21: 811-818, 1994.
9. Brunner, F. P., G. Thiel, M. Hennle, H. A. Bock, and M. J. Mihatsch. Long-term enalapril and verapamil in rats with reduced renal mass. Kidney Int. 36: 969-977, 1989.
10. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
11. DiPette, D. J., B. Waeber, L. Volicer, P. Chao, I. Gavras, H. Gavras, and H. Brunner. Salt-induced hypertension in chronic renal failure: evidence for a neurogenic mechanism. Life Sci. 32: 733-740, 1983.
12. Du, Y., A. Yao, D. Guo, T. Inagami, and D. H. Wang. Differential regulation of angiotensin II receptor subtypes in rat kidney by low dietary sodium. Hypertension Dallas 25: 872-877, 1995.
13. Dworkin, L. D., J. A. Benstein, M. Parker, E. Tolbert, and H. D. Feiner. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms. Kidney Int. 43: 808-814, 1993.
14. Floege, J., R. J. Johnson, K. Gordon, H. Iida, P. Pritzl, A. Yoshimura, C. Campbell, C. E. Alpers, and W. G. Couser. Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int. 40: 477-488, 1991.
15. Fogo, A., E. P. Hawkins, P. L. Berry, A. D. Glick, M. L. Chiang, R. C. Macdonell, and I. Ichikawa. Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis. Kidney Int. 38: 115-123, 1990.
16. 1 expression and phenotypic modulation in the kidney of hypertensive rats. Hypertension Dallas 26: 199-207, 1995.
17. Ikoma, M., T. Kawamura, Y. Kakinuma, A. Fogo, and I. Ichikawa. Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions. Kidney Int. 40: 195-202, 1991.
18. Iwai, N., Y. Yamano, S. Chaki, F. Konishi, S. Bardan, C. Tibbetts, K. Sasaki, M. Hasegawa, and T. Inagami. Rat angiotensin II receptor: cDNA sequence and regulation of the gene expression. Biochem. Biophys. Res. Commun. 177: 299-304, 1991.
19. Janiak, P., A. Pillon, J. F. Prost, and J. P. Vilaine. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 20: 737-745, 1992.
20. Kanagy, N. L., and G. D. Fink. Losartan prevents salt-induced hypertension in reduced renal mass rats. J. Pharmacol. Exp. Ther. 265: 1131-1136, 1992.
21. Kim, S., K. Ohta, A. Hamaguchi, T. Omura, T. Yukimura, K. Miura, Y. Inada, T. Wada, Y. Ishimura, and F. Chatani. Contribution of renal angiotensin II type 1 receptor to gene expressions in hypertension-induced renal injury. Kidney Int. 46: 1346-1338, 1994.
22. Kuncio, G. S., E. G. Neilson, and T. Haverty. Mechanisms of tubulointerstitial fibrosis. Kidney Int. 39: 550-556, 1991.
23. Lafayette, R. A., G. Mayer, S. K. Park, and T. W. Meyer. Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass. J. Clin. Invest. 90: 766-771, 1992.
24. Lee, L. K., T. W. Meyer, A. S. Pollock, and D. H. Lovett. Endothelial-cell injury initiates glomerular sclerosis in the rat remnant kidney. J. Clin. Invest. 96: 953-964, 1995.
25. Llorens-Cortes, C., B. Greenberg, H. Huang, and P. Corvol. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase polymerase chain reaction analysis. Hypertension Dallas 24: 538-548, 1994.
26. Mai, M., H. Geiger, K. F. Hilgers, R. Veelken, J. F. Mann, J. Dammrich, and F. C. Luft. Early interstitial changes in hypertension-induced renal injury. Hypertension Dallas 22: 754-765, 1993.
27. Mayer, G., R. A. Lafayette, J. Oliver, W. M. Deen, B. D. Myers, and T. W. Meyer. Effects of angiotensin II receptor blockade on remnant glomerular permselectivity. Kidney Int. 43: 346-353, 1993.
28. Pamnani, M. B., S. Chen, H. J. Bryant, J. F. Schooley, and F. J. Haddy. Effect of increased dietary calcium on the development of reduced renal mass saline hypertension in rats. J. Am. Coll. Nutr. 9: 35-43, 1990.
29. Pelayo, J. C., A. H. Quan, and P. F. Shanley. Angiotensin II control of the renal microcirculation in rats with reduced renal mass. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F414-F422, 1990.
30. Pollock, D. M., B. J. Divish, J. S. Polakowski, and T. J. Opgenorth. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. J. Pharmacol. Exp. Ther. 267: 657-663, 1993.
31. 1. Nucleic Acids Res. 18: 3059, 1990.
32. Roberts, A. B., S. J. Kim, and T. Noma. Multiple forms of TGF: distinct promoters and differential expression. In: Clinical Applications of TGF, edited by M. B. Sporn and A. B. Roberts. Chichester, UR: Wiley, 1991, p. 7-28. (Ciba Found. Symp.)
33. Roberts, A. B., and M. B. Sporn. The transforming growth factor. In: Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors, edited by M. B. Sporn and A. B. Roberts. Heidelberg: Springer-Verlag, 1990, vol. 95, pt. I, p. 419-472.
34. Rocco, M. V., and F. N. Ziyadeh. Transforming growth factor: an update on systemic and renal actions. In: Hormones, Autacoids, and the Kidney: Contemporary Issues in Nephrology, edited by S. Goldfarb and F. N. Ziyadeh. New York: Churchill-Livingstone, 1991, p. 391-410.
35. Tufro-McReddie, A., R. L. Chevalier, A. D. Everett, and R. A. Gomez. Decreased perfusion pressure modulates renin and ANG II type I receptor gene expression in rat kidney. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R696-R702, 1993.